Olanzapine Tablet, Film Coated
Product Images NDC 43598-166

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 43598-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton2 (Carton2)

Each pack of Olanzapine Tablets, USP contains 5mg of the drug. This medication is not suitable for children. It is recommended to store it in a temperature-controlled environment. For complete dosage information, consult the enclosed pamphlet or contact the manufacturer, Dr. Reddys. These tablets are manufactured in India by Boday's Laboratories Limited and are distributed by Dr Reddys in the USA.*

FDA Label Image

Carton3 (Carton3)

This is a medication package of Olanzapine Tablets, USP (7.5mg). The package contains all the necessary information for proper dosage administration and storage. It should not be used for children. The manufacturer is Dr. Reddy's Laboratories Limited located in India at Bachpaly - 500 090.*

FDA Label Image

Carton4 (Carton4)

This is a package of Olanzapine Tablets, USP containing 10mg of the active ingredient. It should be stored at room temperature and kept away from children. It is manufactured by Boday's Laboratories Limited in India.*

FDA Label Image

Container2 (Container2)

FDA Label Image

Container3 (Container3)

Not available.*

FDA Label Image

Container4 (Container4)

FDA Label Image

Srtucture (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.